Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human body. The softening IV needle is rigid at room temperature, similar to ...
Niagen Bioscience (NAGE) announced that its pharmaceutical-grade Niagen Plus products, Niagen IV and injections, are now offered at more than 50 iCRYO locations across the U.S., bringing total ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...
U.S. FDA-registered 503B outsourcing facility, Wells Pharma of Houston, will compound and distribute Niagen (nicotinamide riboside chloride) IV and injections to 14 new clinics LOS ANGELES--(BUSINESS ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...
People, I think, have started looking outside the box when it comes to health care. And they’re turning more to wellness and ...
– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback